Polish guidelines for the diagnosis and management of osteoporosis: A review of 2013 update

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 5, 2014, Pages 255-263

  Głuszko, Piotr ^a   Lorenc, Roman S ^b   Karczmarewicz, Elzbieta ^b   Misiorowski, Waldemar ^c   Jaworski, Maciej ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

FRAX ; Osteoporosis management; Osteoporotic fractures

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DENOSUMAB; IBANDRONIC ACID; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE; VITAMIN D; ZOLEDRONIC ACID;

ALGORITHM; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; BREAST CANCER; CORTICOSTEROID THERAPY; DENSITOMETRY; FEMUR FRACTURE; FRAGILITY FRACTURE; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; LUMBAR VERTEBRA; OSTEOMALACIA; OSTEOPOROSIS; PATIENT MONITORING; POLAND; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; REVIEW; SECONDARY OSTEOPOROSIS; SUPPLEMENTATION; CLINICAL PRACTICE; FEMALE; GENERAL PRACTICE; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; STANDARDS;

FAMILY PRACTICE; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; POLAND; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT;

EID: 84901657106     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2255     Document Type: Review

References (30)

1. Kanis JA, McCloskey EV, Johansson H, et al. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013; 24: 23-57.
2. Lorenc R, Głuszko P, Karczmarewicz E, et al. [Polish guidance for the diagnosis and management of osteoporosis. 2013 Update], Medycyna Praktyczna. 2013; (Wyd. Spec. Reumatologia): 1-44. Polish.
3. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC, USA, NOF 2013.
4. Jaworski M., Lorenc R.S. Risk of hip fracture in Poland. Med Sci Moni. 2007; 13: 205-210.
5. Czerwinski E, Kanis JA, Osieleniec J, et al. Evaluation of FRAX to characterise fracture risk in Poland. Osteoporos Int. 2011; 22: 2507-2512.
6. Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 2013; 75: 392-396.
7. Lekamwasam S, Adachi JD, Agnusdei D, et al. Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int. 2012; 23: 2257-3376.
8. Rubin KH, Abrahamsen B, Friis-Holmberg T, et al. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone. 2013; 56: 16-22.
9. Leslie WD, Brennan SL, Lix LM, et al. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women. Arch Osteoporos. 2013; 8: 145.
10. Scottish Intercollegiate Guidelines Network (SIGN): Methodology Review Group. Report on the review of the method of grading guideline recommendations. Edinburgh, SIGN, 1999.
11. Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323: 334-336.
12. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ. Tech Rep Ser. 1994; 843: 1-129.
13. Lakatos P, Balogh A, Czerwinski E, et al. Members of the "3rd Summit on Osteoporosis - Central and Eastern Europe (CEE)". New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the "3rd Summit on Osteoporosis-CEE", November 2009, Budapest, Hungary. Arch Osteoporos. 2011; 6: 1-12.
14. Lorenc RS, Resch H, on behalf of the Members of the "2nd Summit on Osteoporosis - Central and Eastern Europe (CEE)" Management of osteoporosis in central and eastern Europe (CEE): conclusions of the "2nd Summit on Osteoporosis-CEE", 21-22 November 2008, Warsaw, Poland. Arch Osteoporos. 2009; 4: 1-8.
15. Łukaszkiewicz J, Karczmarewicz E, Płudowski P, et al. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study. Med Sci Monit. 2008; 14: 65-70.
16. Franek E, Karczmarewicz E, Misiorowski W, et al. Treatment benefits evaluation in osteoporosis: Position of the summit international conference on osteoporosis - Central- Eastern Europe held 21-22 November 2008, Warsaw, Poland. Bone. 2009; 44: S374-S375.
17. Płudowski P, Karczmarewicz E; Central Europe Expert Group. Practical guidelines for the supplementation of vitamin D and treatment of deficits in Central Europe - recommended vitamin D intake in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64: 239-246.
18. Kanis JA, Borgström F, Compston J, et al. SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos. 2013; 8: 144.
19. Lakatos P, Szekeres L, Takács I, et al. [Diagnostic and therapeutic guidelines for the age-related and glucocorticoid-induced osteoporosis - 2011, Hungary]. Magyar Reumatológia, 2011; 1: 28-33. Hungarian.
20. Lakatos P, Takács I, Szekeres L, et al. Reumatológiai és Fizioterápiás Szakmai Kollégium: A korral járó és a kortikoszteroidok indukálta osteoporosis diagnosztikus és terápiás protokollja - 2011. Háziorvosi Útmutató Klinikai Irányelvek Kézikönyve, Medition Kiadó, Budapest, 2010; 3: 215-224. Hungarian.
21. DVO Guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults. Osteologie. 2011; 20: 55-74.
22. Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012; 23: 2579-2589.
23. Body JJ, Bergmann P, Boonen S, et al. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int. 2010; 21: 16 571-1680.
24. Briot K, Corfet B, Thomas T, et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine. 2012; 79: 304-313.
25. Papaioannou A, Morin S, Cheung AM, et al.; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010; 182: 1864-1873.
26. Stompor T, Zablocki M, Lesiow M. Osteoporosis in mineral and bone disorders of chronic kidney disease. Pol Arch Med Wewn. 2013; 123: 314-320.
27. Muñoz-Ortego J, Vestergaard P, Rubio JB, et al. Ankylosing spondylitis is associated with increased risk of vertebral and non-vertebral clinical fractures: a population-based cohort study. J Bone Miner Res. 11 Mar 2014. doi: 10.1002/jbmr.2217. Epub ahead of print.
28. Holick MF, Binkley NC, Bishoff-Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-1930.
29. Takacs I, Benko I, Toldy E, et al. Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases. Orv Hetil. 2012; 153: 5-26.
30. Dawson-Hughes B, Mithal A, Bonjour JP et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010; 21: 1151-1154.